CVE-2015-3954: Hospira Plum A+ Infusion System vulnerability
Hospira · Plum A+ Infusion System
Affected: Hospira Plum A+ Infusion System · Exploitation: possible (1 to 10%)
Not in CyberSIXT coverage yet: no article names this CVE. This page shows the public record.
Higher than 81% of scored CVEs
Not scored yet. The CVE record carries no CVSS score.
DescriptionCVE.org
Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior give unauthenticated users root privileges on Port 23/TELNET by default. An unauthorized user could issue commands to the pump. Hospira recommends that customers close Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.
Affected products3
From the CVE record. A product or version that is not listed is unknown, not unaffected.
- Hospira · Plum A+ Infusion System<= 13.4
- Hospira · Plum A+3 Infusion System<= 13.6
- Hospira · Symbiq Infusion System<= 3.13
On the Atlas
Every published CVE is on the CyberSIXT Atlas, grouped by weakness, vendor and month.
- Exploitation
- Possible (1 to 10%). EPSS between 1% and 10%.
- CISA KEV
- Not listed
- Public check
- No public nuclei template
- Vendor
- Hospira
- Published
- March 2019
CoverageNo articles yet
No CyberSIXT article names CVE-2015-3954 yet, so there is no coverage timeline, action brief or change log for it. Everything on this page comes from the public CVE record, CISA KEV, EPSS and the nuclei template index. Search the archive or see the CVEs in the news.